Schroder Investment Management Group
ARNA

Schroder Investment Management Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Schroder Investment Management Group’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-70,916
Closed -$6.59M – 1648
2021
Q4 		$6.59M Sell
70,916
-1,246
-2% -$82.1K 0.01% 695
2021
Q3 		$4.3M Buy
72,162
+6,065
+9% +$358K 0.01% 818
2021
Q2 		$4.51M Buy
66,097
+6,384
+11% +$416K 0.01% 845
2021
Q1 		$4.14M Buy
59,713
+11,259
+23% +$866K 0.01% 859
2020
Q4 		$3.72M Buy
48,454
+6,253
+15% +$469K 0.01% 870
2020
Q3 		$3.16M Buy
42,201
+10,586
+33% +$706K 0.01% 812
2020
Q2 		$1.99M Sell
31,615
-217,699
-87% -$12M ﹤0.01% 827
2020
Q1 		$11.8M Buy
249,314
+183,378
+278% +$8.41M 0.03% 508
2019
Q4 		$3M Sell
65,936
-4,278
-6% -$202K ﹤0.01% 819
2019
Q3 		$3.21M Buy
70,214
+43,242
+160% +$2.43M 0.01% 825
2019
Q2 		$1.58M Buy
+26,972
New +$1.39M ﹤0.01% 853

Schroder Investment Management Group's ARNA Position: Q1 2022 in Review

Schroder Investment Management Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 70,916 shares — an estimated $6.59M sold.

Schroder Investment Management Group first reported a position in ARNA in Q2 2019 and held it in 11 quarters. The position peaked at $11.8M in Q1 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Schroder Investment Management Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Schroder Investment Management Group sold 70,916 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $6.59M.
  • Schroder Investment Management Group first reported a position in Arena Pharmaceuticals Inc in Q2 2019 and held it in 11 quarters.
  • Schroder Investment Management Group's Arena Pharmaceuticals Inc position peaked at $11.8M in Q1 2020.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Schroder Investment Management Group's 13F filing for Q1 2022, filed 16 May 2022.